The applicant for a generic drug permit license shall, in accordance with Article 48-9 of the Act, submit the completed application form in Annex II, along with the dossiers required by registration, to the Central Competent Health Authority.In the preceding Paragraph, the applicant shall fill in the patent information of the reference drug in the Registration System. If the invention patent refers to medical use, the number of claims shall be concurrently provided. Those applicants that are originally subject to provisions of Item 1 to Item 3 of Article 48-9 of the Act and then switch to Item 4 of the same Article shall fill out the declaration form in Annex II, and the date on which the declaration form is sent to the Central Competent Health Authority shall be the application date.